| Literature DB >> 35521576 |
Xiaofeng Zhang1, Qiongbo Hu1, Qunfang Weng1.
Abstract
Both Isaria cicadae and Isaria tenuipes are important entomopathogenic fungi used in health foods and traditional herbal medicines in East Asia. However, the safety concerns for both fungal species have been attracting significant attention. Thus, surveying their secondary metabolites (SMs) will be beneficial to improving the safety of their fungal products. In the case of I. cicadae, its SMs mainly include nucleosides, amino acids, beauvericins, myriocin, and oosporein. In contrast, trichothecene derivatives, isariotins, cyclopenta benzopyrans and PKs, are found in the case of I. tenuipes. Among them, beauvericins, myriocin, oosporein and many trichothecene derivatives are toxic compounds. The toxicity and side effects of the fungal products may be related to these SMs. Thus, to ensure the safety of fungal products, the residues standards of SMs need to be reported. Furthermore, methods for the detection of their SMs and biological identification of their strains must be considered. This review gives new insight into the secondary metabolites of medical and edible fungi. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35521576 PMCID: PMC9059538 DOI: 10.1039/c8ra09039d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1General characteristics and morphology of Isaria cicadae and Isaria tenuipes. (A–D) Isaria cicadae (http://www.thai2bio.net/; http://www.biophar.cn/) and (E–F) Isaria tenuipes (http://www.naro.affrc.go.jp/). (A) and (E) wild complex of fruiting body and host, FB: fruiting bodies, HI: host insects, (B) and (F) microscopic photos, CS: conidial structures, (C) cultured fruiting bodies and (D) commercial product.
SMs isolated from I. cicadae and their biological activities
| Metabolite | CAS no. | Material source | Biological activity |
|---|---|---|---|
| Cordycepin (1) | 73-03-0 | Sporoderm-broken spore powders of wild | Immunomodulatory, antibacterial, antiviral, and anti-tumor effects on cells |
|
| 4338-48-1 | Cultivated complex of fruit body of | |
| Cordycepic acid (3) | 69-65-8 | Sporoderm-broken spore powders of wild | Bacteriostatic activity |
| Betaine (4) | 107-43-7 | Mycelia of | Regulate internal osmotic pressure, relieve stress, and promote fat metabolism and protein synthesis |
| Hercynine (5) | 534-30-5 | Mycelia of | Antioxidant |
| Ergothioneine (6) | 497-30-3 | Mycelia of | Antioxidant |
| Fumimycin (7) | 942472-95-9 | Mycelia, cultivated complex of fruit body of | |
| Cordysinin A (8) | 1330197-09-5 | Mycelia of | Inhibiting the proliferation of human glioma U87 mg and U251 cells. Anti-inflammatory activity in human neutrophils |
| Beauvericin (9) | 26048-05-5 | Mycelia, cultivated complex of fruit body of | |
| Beauvericin A (10) | 165467-50-5 | Wild complex of fruit body of | Significant inhibitory effect on hepg2 and hepg2/ADM cells with IC50 values ranging from 2.40–14.48 μM. Cytotoxicity against hepg2/ADM cell line with IC50 value 25-fold more sensitive to doxorubicin |
| Beauvericin E (11) | 728912-27-4 | Wild complex of fruit body of | Significant inhibitory effect on hepg2 and hepg2/ADM cells with IC50 values ranging from 2.40–14.48 μM |
| Beauvericin J (12) | 1342821-26-4 | Wild complex of fruit body of | Significant inhibitory effect on hepg2 and hepg2/ADM cells with IC50 values ranging from 2.40–14.48 μM |
| Cordycecin A (13) | 1799406-02-2 | Wild complex of fruit body of | |
| Aspergilliamide (14) | 1691204-76-8 | Mycelia of | Medium brine shrimp toxicity |
| Myriocin (15) | 35891-70-4 | Sporoderm-broken spore powders of wild | Serine palmitoyltransferase inhibitor |
| Phytosphingosine (16) | 554-62-1 | Mycelia, cultivated complex of fruit body of | |
| Oosporein (17) | 475-54-7 | Mycelia, cultivated complex of fruit body of | Food refusal effect on crop pests |
| Stipitatonic acid (18) | 606-39-3 | Mycelia, cultivated complex of fruit body of | Bactericidal and insecticidal activities, as well as growth-inhibitory effects on some pathogenic fungi |
| Cycloheximide acid A (19) | 1610848-67-3 | Mycelia, cultivated complex of fruit body of | |
| 2-(3-Carboxy-2-hydroxypropyl)-3-methyl-2-cyclopentenone (20) | 1019196-97-4 | Cultivated mycelia of | |
| 5-(2-Hydroxyethyl)-2-furanacetic acid (21) | 1018901-08-0 | Cultivated mycelia of | |
| Lichenicolin A (22) | 883977-62-6 | Mycelia, cultivated complex of fruit body of | |
| 2-(5-(3-Oxobutyl)furan-2-yl)acetic acid (23) | A strain of cell fusion from | Weak inhibitory activity against AChE | |
| Cordycepone (24) | A strain of cell fusion from | ||
| Cephalosporolide E (25) | 97373-15-4 | A strain of cell fusion from | |
| Cephalosporolide J (26) | 97344-02-0 | A strain of cell fusion from | |
| Methyl-2-(5-(3-hydroxybutyl)furan-2-yl)acetate (27) | 851868-04-7 | A strain of cell fusion from | Weak inhibitory activity against AChE |
| 2-(5-(3′-Hydroxybutyl) furan-2-yl) acetic acid (28) | 170445-59-7 | A strain of cell fusion from | Weak inhibitory activity against AChE |
| α-furoic acid (29) | 88-14-2 | A strain of cell fusion from | Weak inhibitory activity against AChE. Moderate inhibitory activity against the nematode |
| (22 | 57-87-4 | A strain of cell fusion from | |
| 3-Benzyl-6-isopropyl-2,5-piperazinedione (31) | 14474-71-6 | A strain of cell fusion from | Moderate inhibitory activity against the nematode |
| 3-Isobutyl-6-isobutylpiperazine-2,5-dione (32) | 5625-50-3 | A strain of cell fusion from |
Fig. 2Structures of the SMs isolated from I. cicadae.
SMs isolated from Isaria tenuipes and their biological activities
| Metabolites | CAS no. | Material source | Biological activity |
|---|---|---|---|
| Cephalosporolide B (33) | 97344-03-1 | Culture broth | |
| Cephalosporolide F (34) | 97344-04-2 | Culture broth of | Moderate inhibitory activity against the nematode |
| Tenuipyrone (35) | 1354559-27-5 | Culture broth of | |
| Cephalosporolide C (36) | 97344-02-0 | Culture broth of | |
| (4 | 2098945-28-7 | Culture broth of | Inhibit prostate cancer cells 22RV1 and DU-145 at the rates of 32.5% and 40.6% at 5 μmol L−1, respectively |
| (3 | 2101845-87-6 | Culture broth of | Inhibit prostate cancer cells 22RV1 and DU-145 at the rates of 37.8% and 38.6% at 5 μmol L−1, respectively |
| 4-β-Acetoxyscirpendiol (39) | 2531-11-5 | Cultivated fruiting bodies of | Induces apoptosis of human leukemia cells (HL-60). Lower blood sugar levels in the circulatory system as effective SGLT-1 inhibitors |
| Tenuipesine A (40) | 816448-01-8 | Cultivated fruiting bodies of | |
| Paecilomycine A (41) | 594840-03-6 | Cultivated fruiting bodies of | Activity in neurotrophic factor biosynthesis in glial cells |
| Paecilomycine B (42) | 594840-04-7 | Cultivated fruiting bodies of | |
| Paecilomycine C (43) | 765942-39-0 | Cultivated fruiting bodies of | |
| Spirotenuipesine A (44) | 594840-05-8 | Cultivated fruiting bodies of | Potent activity in neurotrophic factor biosynthesis in glial cells |
| Spirotenuipesine B (45) | 594840-06-9 | Cultivated fruiting bodies of | Potent activity in neurotrophic factor biosynthesis in glial cells |
| Penostatin A (46) | 173485-70-6 | Mixture of cultivated mycelium and medium of | Protein phosphatase 1B inhibitors |
| Penostatin B (47) | 173655-56-6 | Mixture of cultivated mycelium and medium of | Protein phosphatase 1B inhibitors |
| Penostatin C (48) | 173485-71-7 | Mixture of cultivated mycelium and medium of | Protein phosphatase 1B inhibitors |
| Penostatin J (49) | 1695557-12-0 | Mixture of cultivated mycelium and medium of | Protein phosphatase 1B inhibitors |
| Isariotin A (50) | 952703-96-7 | Culture broth of | Marginal activity against the |
| Isariotin B (51) | 952703-97-8 | Culture broth of | |
| Isariotin C (52) | 952703-98-9 | Culture broth of | Marginal activity against the |
| Isariotin D (53) | 952703-99-0 | Culture broth of | Marginal activity against the |
| Isariotin E (54) | 1137665-60-1 | Culture broth of | |
| Isariotin F (55) | 1137665-61-2 | Culture broth of | Antimalarial activity against |
| TK-57-164A (60) | 745050-50-4 | Culture broth of | Antimalarial activity; cytotoxic activities against KB, MCF-7, NCI-H187 and Vero cells |
| Isariotin G (56) | 1383930-91-3 | Culture broth of | Antimalarial activity; cytotoxic activities against KB, MCF-7, NCI-H187 and Vero cells |
| Isariotin H (57) | 1383930-93-5 | Culture broth of | Antimalarial activity; cytotoxic activities against KB, MCF-7, NCI-H187 and Vero cells |
| Isariotin I (58) | 1383930-95-7 | Culture broth of | Antimalarial activity; cytotoxic activities against KB, MCF-7, NCI-H187 and Vero cells |
| Isariotin J (59) | 1383930-97-9 | Culture broth of | Antimalarial activity; cytotoxic activities against KB, MCF-7, NCI-H187 and Vero cells |
| Hanasanagin (61) | 1187336-16-8 | Fruiting body of | Antioxidant activity |
| 3′-Deoxyhanasanagin(3,4-diguanidinobutanoyl-tyrosine) (62) | 1187059-33-1 | Fruiting body of |
Fig. 3Structures of SMs isolated from I. tenuipes.
Toxicity tests of the two Isaria fungi
| Material source | Toxicity descript |
|---|---|
| Freeze-dried powder of | A total of eighty 8 week-old Sprague Dawley rats were divided into 4 groups (10 males and 10 females in each group). |
| Water extract from the powder of wild | No acute toxicity to mice even at a dosage 80 g kg−1 for 7 days, which was 444 times the clinical daily dosage |
| Water extract from the powder of | No toxicological effects to the adult Sprague Dawley rats orally treated at doses of 0.008–5 g kg−1 body weight for 2 weeks, except for a decline in the weight of the thymus in the males |
| Extract of phosphate buffered saline (PBS) from the complex of the fruiting bodies of | In the Ames test, no mutagenic response in the absence or presence of 59 mix with TA98, TA100, TA1535, and TA1537. In the chromosome aberration (CA) test, no significant effect on Chinese hamster ovary (CHO) cells. In the micronuclei (MN) test, no significant change in the occurrence of micronucleated polychromatic erythrocytes in male ICR mice intraperitoneally administered at doses of 15, 150, or 1500 mg kg−1 |
| Powder of the cultured fruiting bodies of | Kidney toxicity was investigated after 13 weeks of administering the complex orally to Sprague Dawley rats at doses of 0, 5000, 10 000, and 50 000 ppm. Dose-dependent kidney cell karyomegaly and tubular hypertrophy were observed, with higher severity in males. There was a dose-dependent increase in kidney injury molecule 1 (KIM-1) and tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) levels in the kidney and urinary KIM-1, cystatin C, b2m, and osteopontin levels. KIM-1 and TIMP-1 increased in the male kidneys, and they did not recover 2 weeks after stopping exposure. Cystatin C in the kidney was significantly lowered in all treatment groups at 13 weeks of administration. All the changes were more noticeable in males. These data indicate that the complex damages renal tubule cells with histopathological lesions and changes in biomarker levels. Kidney and urinary KIM-1 and cystatin C were the most markedly affected and early increased indicators among the biomarkers tested; whereas, blood urea nitrogen (BUN) and creatinine were not affected |
| Aqueous and ethanol extracts of | In acute toxicity, neither mortality nor toxicological signs were found in mice and rats with the maximum tolerance dose of 15 g kg−1. No mortality or adverse effects was observed in the subchronic toxicity studies, in which no significant difference in bodyweight, relative organ weight or hematological parameters, and no abnormality of internal organs were found between the treatment and control groups |
| Water extract from the powder of fruiting bodies of | The acute oral LD50 to Sprague Dawley rats was estimated to be greater than 2000 mg kg−1 of body weight. In the subchronic study, the oral treatment of rats with 500, 1000 or 2000 mg kg−1 daily for 13 weeks did not induce any dose-related changes (body weight, food consumption, clinical observation, urinalysis, hematology, clinical chemistry and organ weight). In contrast, histopathological observation revealed that the extract induced karyomegaly in the outer medulla of the kidney in all the treated rats. In the Ames tests, the extract significantly produced His+ mutants at the highest concentration of 5000 lg per plate in |